Tenaris: BofA Global Research raises price objective to EUR 30 from EUR 28
TS•BofA Global Research raised its price objective for Tenaris to EUR 30 from EUR 28.
Related News
Phio Pharmaceuticals to present at NIBA 153rd Conference, updates PH-762 program
PHIO•
Press digest: Canada — October 5
SU•
AIBotics names Empulser founder Patrick Tsang strategic adviser, eyes CEO appointment after deal closes
AIBT•
Nurix extends Gilead collaboration for oncology program
NRIX•
Antero Resources target price cut to $46 from $52
AR•